Lipoxin (LTX A4 5S, 6R, 15R) levels drastically decrease after 5 years of hemodialysis treatment

• Autorzy: Szczuko M. , Palma J. , Drozd A. , Stachowska E. , Marlicz W. , Malgorzewicz S. , Debska-Slizien A. , Rutkowski P. , Kaczkan M.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

chronic kidney disease; hemodialysis therapy; patient; fatty acid; arachidonic acid; cyclooxygenase; lipoxin; prostaglandin; thromboxane; oxidative stress; hydroxyoctadecadienoic acid; hydroxyeicosatetraenoic acid

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 3
• Opis fizyczny: p.389-398,fig.,ref.

Twórcy

autor

Szczuko M.

• Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland

autor

Palma J.

• Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland

autor

Drozd A.

• Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland

autor

Stachowska E.

• Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland

autor

Marlicz W.

• Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

autor

Malgorzewicz S.

• Department of Clinical Nutrition, Medical University of Gdansk, Gdansk, Poland

autor

Debska-Slizien A.

• Department of Microbiology and Immunology, Pomeranian Medical University, Szczecin, Poland

autor

Rutkowski P.

• General Nursery Department, Medical University of Gdansk and Diaverum Hemodialysis Unit, Gdansk, Poland

autor

Kaczkan M.

• Department of Clinical Nutrition, Medical University of Gdansk, Gdansk, Poland

Identyfikatory

DOI

10.26402/jpp.2020.3.10